Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme (1 selected)

Guidance programme

Showing 726 to 750 of 771

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Telbivudine for the treatment of chronic hepatitis BTA154
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitusTA151
Bevacizumab for the treatment of non-small-cell lung cancer (terminated appraisal)TA148
Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal)TA149
Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neckTA145
Adalimumab for the treatment of adults with psoriasisTA146
Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and overTA138
Structural neuroimaging in first-episode psychosisTA136
Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphomaTA137
Infliximab for the treatment of adults with psoriasisTA134
Pemetrexed for the treatment of malignant pleural mesotheliomaTA135
Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 yearsTA131
Bortezomib monotherapy for relapsed multiple myelomaTA129
Stapled haemorrhoidopexy for the treatment of haemorrhoidsTA128
Pemetrexed for the treatment of non-small-cell lung cancerTA124
Varenicline for smoking cessationTA123
Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade gliomaTA121
Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemiaTA119
Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapyTA117
Methadone and buprenorphine for the management of opioid dependenceTA114
Naltrexone for the management of opioid dependenceTA115
Gemcitabine for the treatment of metastatic breast cancerTA116
Laparoscopic surgery for colorectal cancerTA105
Etanercept and efalizumab for the treatment of adults with psoriasisTA103
Docetaxel for the treatment of hormone-refractory metastatic prostate cancerTA101

Results per page

  1. 10
  2. 25
  3. 50
  4. All